arrow_back Back to App

US Support for Global Vaccines: Protecting Health and National Security

This House Resolution affirms continued US financial support for Gavi, the Vaccine Alliance, to save children's lives and combat infectious diseases globally. The resolution emphasizes that these investments are a critical component of US health security, reducing the risk of outbreaks reaching American soil. It encourages multiyear funding commitments to maximize Gavi's impact in low-income countries.
Key points
Continued US funding for Gavi to deliver essential vaccines (including malaria and Ebola) to low-income countries.
Enhancing US health security by stemming infectious disease outbreaks at their source globally.
Recognizing the high return on investment: $1 invested yields $54 in global health and economic savings.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_848
Sponsor: Rep. Kean, Thomas H. [R-NJ-7]
Process start date: 2025-10-31
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi").

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_848.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-10-31.

What are the main provisions?

Key points include:

  • Continued US funding for Gavi to deliver essential vaccines (including malaria and Ebola) to low-income countries.
  • Enhancing US health security by stemming infectious disease outbreaks at their source globally.
  • Recognizing the high return on investment: $1 invested yields $54 in global health and economic savings.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kean, Thomas H. [R-NJ-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Economy